USED AS CONTRAST MEDIUM FOR DIAGNOSTIC MRI FOR THE DETECTION OF LESIONS OF THE LIVER SUSPECTED TO BE DUE TO METASTATIC DISEASE OR HEPATOCELLULAR CARCINOMAS. AS AN ADJUNCT TO MRI TO AID IN THE INVESTIGATION OF FOCAL PANCREATIC LESIONS.
IT SHOULD BE ADMINISTERED AS AN IV INFUSION AT THE RATE OF 2-3 ML/MIN FOR LIVER IMAGING AND AT A RATE OF 4-6 ML/MIN FOR IMAGING OF THE PANCREAS.
ADULTS :
THE RECOMMENDED DOSE IS 0.5 ML/KG BODYWEIGHT (5 ?MOL/KG BODYWEIGHT). THIS CORRESPONDS TO A DOSE OF 35 ML FOR A 70 KG PERSON. ABOVE 100 KG BODY WEIGHT, 50 ML IS USUALLY SUFFICIENT.
CHILDREN AND ADOLESCENTS : SAFETY NOT DOCUMENTED